Pharma & Biopharma Manufacturing
Samsung Epis Holdings Established as New Biotechnology Investment Holding Company Following Spin-Off from Samsung Biologics
Samsung Epis Holdings Co., Ltd.announced its establishment as a new investment holding company, following the spin-off of Samsung Bioepis Co., Ltd. from Sa...
November 04, 2025 | News
Lonza to Acquire Redberry SAS, Advancing Rapid Microbiology Testing with Solid-Phase Cytometry Technology
Lonza, one of the world’s largest contract development and manufacturing organizations (CDMOs), announced that it has signed an agreement to acquire ...
October 31, 2025 | News
Everest Medicines Expands into Ophthalmology with Exclusive License for VIS-101 from Visara, a NovaBridge Subsidiary
Everest Medicines announced that it has acquired an exclusive license with Visara, Inc. (“Visara”), a subsidiary of NovaBridge Biosciences (for...
October 31, 2025 | News
Starna Therapeutics Secures Over RMB 300 Million in Series B Financing to Accelerate in vivo CAR-T Innovation
Starna Therapeutics, a pioneering biotechnology company developing next-generation RNA and in vivo CAR-T therapies, today announced the successful closing ...
October 30, 2025 | News
NEOM and WuXi AppTec Partner to Build World-Class Pharmaceutical R&D and Manufacturing Capabilities in Saudi Arabia
NEOM, the sustainable region taking shape in northwest Saudi Arabia, has signed a strategic memorandum of understanding (MoU) with WuXi AppTec, a leading g...
October 28, 2025 | News
Curia Invests $4 Million to Upgrade API Aseptic Suites in Spain to Meet New EU GMP Annex 1 Standards
Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of a $4 million investmen...
October 28, 2025 | News
Single Use Support Expands ISO 7 Cleanroom Capacity in Austria to Strengthen Global Biopharma Supply Chains
New ISO 7-certified facility in Austria boosts production volumes, ensures secure supply chains, and meets increasing global demand for flexible single-use...
October 28, 2025 | News
WuXi AppTec Reports RMB32.86 Billion Revenue for First Three Quarters of 2025, Up 18.6% Year-on-Year
Q3 Total Revenue: RMB12.06 Billion, Up 15.3% YoY; Revenue from Continuing Operations[1]Reached RMB12.04 Billion, Up 19.7% YoY Q1-Q3 Total Re...
October 27, 2025 | Company results
AGC Biologics Partners With Rarity PBC To Advance First U.S. Commercial Gene Therapy for ADA-SCID
Collaboration will leverage AGC Biologics’ commercial manufacturing experience and proven platforms to seek regulatory approval for a therapy treat...
October 24, 2025 | News
Cambrex Announces $120 Million U.S. Expansion to Strengthen API Manufacturing and Peptide Therapeutics Capabilities
Cambrex, a leading global contract development and manufacturing organization (CDMO), announced a $120 million investment to expand i...
October 23, 2025 | News
SunRock Biopharma and Chime Biologics Partner to Advance Novel Anti-CCR9 Antibody Therapy for Inflammatory Bowel Disease
SunRock Biopharma, a biotechnology company focused on developing next-generation therapeutic antibodies, and Chime Biologics, a global leading contrac...
October 22, 2025 | News
Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, announced that it has successfully completed the acquisition of Prothya Biosolutions ...
October 21, 2025 | News
ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
Dedicated facilities for gelatin and HPMC; 200+ jobs; operations targeted for early 2027; expands ACG's 25-year U.S. presence ACG, the world's most integr...
October 21, 2025 | News
Building Trust Through Quality: How QMS Powers Manufacturing Excellence in Life Sciences
Life sciences sector, a robust Quality Management System (QMS) has become the cornerstone of manufacturing excellence. This is especially true for the medi...
October 16, 2025 | Analysis
Most Read
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
